Free bluetongue tests now available in high-risk counties
The most recent case of BTV-3 in England was confirmed in March 2024.
Free bluetongue testing has been made available to livestock keepers in areas of England where there is considered to be a high risk of the virus being introduced.
The tests are free for livestock being moved from high-risk counties to live in other parts of Great Britain and for animals being sold at a market in a high-risk county where there will be buyers from outside the high-risk counties.
The high-risk countries, all along the east coast of England, are Norfolk, Suffolk, Essex, Kent and East Sussex.
Between November 2023 and March 2024, there were 126 confirmed cases of BTV-3 in England. Although there are have been no confirmed cases of the virus since 8 March 2024, there is considered to be a very high chance that bluetongue virus serotype 3 (BTV-3) will be reintroduced to livestock in Great Britain this year by windborne midges from northern Europe.
There is ongoing surveillance of both midges and susceptible animals. The Department for Environment, Food and Rural Affairs is also currently engaging with vaccine manufacturers about the development of a safe and effective vaccine for BTV-3.
Christine Middlemiss, UK chief veterinary officer, said: “Bluetongue does not pose a threat to human health or food safety, but the disease can impact livestock farms, and cause productivity issues.
“We know that the likelihood of bluetongue virus entering Great Britain is increasing and so I would urge farmers to remain vigilant and report any suspicions to the Animal and Plant Health Agency.
“If you intend to move animals to live out of high-risk counties please take advantage of this free testing as it will help stop the movement of undetected disease.”
Bluetongue is a notifiable disease and any suspicion of it in animals in England must be reported to the Animal and Plant Health Agency on 03000 200 301.
Details about how to apply for free testing can be found here.
Image © Shutterstock
BSAVA is to partner with BVA Live (11-12 June 2026) to champion clinical research.
